BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 24148324)

  • 21. Relation of platelet aggregation and fibrinogen levels to advancing age in aspirin- and thienopyridine-treated patients.
    Koltai K; Feher G; Kenyeres P; Lenart I; Alexy T; Horvath B; Marton Z; Kesmarky G; Toth K
    Clin Hemorheol Microcirc; 2008; 40(4):295-302. PubMed ID: 19126992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of non-inhibited platelet supplementation on platelet reactivity in patients treated with prasugrel or ticagrelor for an acute coronary syndrome: An ex vivo study.
    Bonhomme F; Bonvini R; Reny JL; Poncet A; Fontana P
    Platelets; 2015; 26(4):324-30. PubMed ID: 25905916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-dose aspirin in dogs increases vascular resistance with limited additional anti-platelet effect when combined with potent P2Y12 inhibition.
    Björkman JA; Zachrisson H; Forsberg GB; von Bahr H; Hansson GI; Warner TD; Nylander S
    Thromb Res; 2013 Apr; 131(4):313-9. PubMed ID: 23419412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Rivaroxaban on Platelet Activation and Platelet-Coagulation Pathway Interaction: In Vitro and In Vivo Studies.
    Perzborn E; Heitmeier S; Laux V
    J Cardiovasc Pharmacol Ther; 2015 Nov; 20(6):554-62. PubMed ID: 25848131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of aspirin resistance on platelet function profiles in patients on long-term aspirin and clopidogrel after percutaneous coronary intervention.
    Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Ramírez C; Sabaté M; Jimenez-Quevedo P; Hernández R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Costa MA; Bass TA; Macaya C
    Am J Cardiol; 2006 Jan; 97(1):38-43. PubMed ID: 16377281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of ex vivo autologous and in vivo platelet transfusion in the reversal of P2Y12 inhibition by clopidogrel, prasugrel, and ticagrelor: the APTITUDE study.
    O'Connor SA; Amour J; Mercadier A; Martin R; Kerneis M; Abtan J; Brugier D; Silvain J; Barthélémy O; Leprince P; Montalescot G; Collet JP;
    Circ Cardiovasc Interv; 2015 Nov; 8(11):e002786. PubMed ID: 26553698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of atorvastatin or rosuvastatin co-administration on platelet reactivity in patients treated with dual antiplatelet therapy.
    Verdoia M; Nardin M; Sartori C; Pergolini P; Rolla R; Barbieri L; Marino P; Bellomo G; Suryapranata H; De Luca G;
    Atherosclerosis; 2015 Dec; 243(2):389-94. PubMed ID: 26520891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variability in aggregometry response before and after initiation of clopidogrel therapy.
    Meen Ø; Brosstad F; Bjørnsen S; Pedersen TM; Erikssen G
    Scand J Clin Lab Invest; 2009; 69(6):673-9. PubMed ID: 19484660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet function recovery after ticagrelor withdrawal in patients awaiting urgent coronary surgery.
    Hansson EC; Malm CJ; Hesse C; Hornestam B; Dellborg M; Rexius H; Jeppsson A
    Eur J Cardiothorac Surg; 2017 Apr; 51(4):633-637. PubMed ID: 28007881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance.
    Lev EI; Patel RT; Maresh KJ; Guthikonda S; Granada J; DeLao T; Bray PF; Kleiman NS
    J Am Coll Cardiol; 2006 Jan; 47(1):27-33. PubMed ID: 16386660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversal strategy in antagonizing the P2Y12 -inhibitor ticagrelor.
    Hobl EL; Derhaschnig U; Firbas C; Schoergenhofer C; Schwameis M; Jilma B
    Eur J Clin Invest; 2013 Dec; 43(12):1258-61. PubMed ID: 24112116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of aspirin and clopidogrel in healthy men measured by platelet aggregation and PFA-100.
    Madsen EH; Schmidt EB; Maurer-Spurej E; Kristensen SR
    Platelets; 2008 Aug; 19(5):335-41. PubMed ID: 18791939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamic platelet adhesion in patients with an acute coronary syndrome: The effect of antiplatelet therapy.
    Tsoumani ME; Tatsidou PT; Ntalas IV; Goudevenos JA; Tselepis AD
    Platelets; 2016 Dec; 27(8):812-820. PubMed ID: 27337147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clopidogrel (Plavix) and cardiac surgical patients: implications for platelet function monitoring and postoperative bleeding.
    Tanaka KA; Szlam F; Kelly AB; Vega JD; Levy JH
    Platelets; 2004 Aug; 15(5):325-32. PubMed ID: 15370104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic platelet inhibition between Omega-3 and acetylsalicylic acid dose titration; an observational study.
    Bagger H; Hansson M; Kander T; Schött U
    BMC Complement Med Ther; 2020 Jul; 20(1):204. PubMed ID: 32615977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of platelet and inflammatory system activation on outcomes in diabetic patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Kuliczkowski W; Greif M; Gąsior M; Kaczmarski J; Pres D; Poloński L
    Kardiol Pol; 2011; 69(6):531-7. PubMed ID: 21678284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is TRAP-6 suitable as a positive control for platelet reactivity when assessing response to clopidogrel?
    Gremmel T; Calatzis A; Steiner S; Kaider A; Seidinger D; Koppensteiner R; Kopp CW; Panzer S
    Platelets; 2010; 21(7):515-21. PubMed ID: 20624009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of monitoring platelet function by multiple electrode aggregometry in primary coronary artery bypass surgery.
    Mengistu AM; Mayer J; Boldt J; Röhm KD; Suttner SW
    J Cardiothorac Vasc Anesth; 2011 Feb; 25(1):42-7. PubMed ID: 20427204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of P2Y(1) receptor antagonism on the reactivity of platelets from patients with stable coronary artery disease using aspirin and clopidogrel.
    Labarthe B; Babin J; Bryckaert M; Théroux P; Bonnefoy A
    Br J Pharmacol; 2012 May; 166(1):221-31. PubMed ID: 21950486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antithrombotic effects of ximelagatran plus acetylsalicylic acid (ASA) and clopidogrel plus ASA in a human ex vivo arterial thrombosis model.
    Wåhlander K; Eriksson-Lepkowska M; Nyström P; Eriksson UG; Sarich TC; Badimon JJ; Kalies I; Elg M; Bylock A
    Thromb Haemost; 2006 Mar; 95(3):447-53. PubMed ID: 16525572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.